title: Regulatory implications for the use of pharmaceutical markers to improve the detection of human growth hormone.
authors.affiliation: Pharmaceutical Research and Manufacturers of America, 950 F Street, NW, Suite 300, Washington, DC 20004, USA. agoldhammer@phrma.org
authors.forename: Alan
authors.initials: A
authors.lastname: Goldhammer
mesh_terms: D015415:Biomarkers / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004300:Doping in Sports; D004335:Drug and Narcotic Control; D019382:Human Growth Hormone / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015813:Substance Abuse Detection / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015415:Biomarkers; D019382:Human Growth Hormone